bluebird bio’s Post

View organization page for bluebird bio, graphic

137,167 followers

Today, bluebird bio reported second quarter 2024 results and business highlights. Swipe through for updates related to our commercial progress and learn more here: https://lnkd.in/eiwwVPjZ

Down 30% and 80% YTD! Management is running this company into the ground. Promising life changing therapies in fact 3 FDA approved gene therapies and yet no investor confidence! Maybe Girondi was right all along.

Like
Reply
Ike Ogbaa, MD

Vice President & Head of Medical Affairs/Biotech Executive/Strategic Advisor/Investor/ DEI Leader/Futurist/Digital Innovator

2mo

Keep growing!

Like
Reply
Brandon Chackel M.S. ASQ CQA CSQP

Lead Specialist Quality Operations

2mo

Fantastic update!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics